newsfilter
← Latest News
GlobeNewswire·

Surface Oncology Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Surface Oncology, Inc. (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Surface's board